Tuftsin-phosphorylcholine treatment of autoimmune diseases - A benefit and a message from helminths?

Maria Maslinska; Fabrizio De Luca; Kassem Sharif

doi:10.5114/reum.2017.72622

Tuftsin-phosphorylcholine treatment of autoimmune diseases - A benefit and a message from helminths?

Maria Maslinska^*
, Fabrizio De Luca
, Kassem Sharif

^*Corresponding author for this work

Internal Medicine

National Institute of Geriatrics, Rheumatology and Rehabilitation
University of Milan
Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	267-268
Number of pages	2
Journal	Reumatologia
Volume	55
Issue number	6
DOIs	https://doi.org/10.5114/reum.2017.72622
State	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.5114/reum.2017.72622

Cite this

@article{71e4cb70d539428da6b2d9b96fd945c0,

title = "Tuftsin-phosphorylcholine treatment of autoimmune diseases - A benefit and a message from helminths?",

author = "Maria Maslinska and \{De Luca\}, Fabrizio and Kassem Sharif",

year = "2017",

doi = "10.5114/reum.2017.72622",

language = "אנגלית",

volume = "55",

pages = "267--268",

journal = "Reumatologia",